
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 95.530 | 95.530 | 0.000 |
Convertible | 0.590 | 0.590 | 0.000 |
Other | 6.620 | 6.620 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.851 | 15.391 |
Price to Book | 1.910 | 2.059 |
Price to Sales | 1.144 | 1.492 |
Price to Cash Flow | 9.091 | 9.424 |
Dividend Yield | 3.289 | 3.370 |
5 Years Earnings Growth | 10.093 | 9.057 |
Name | Net % | Category Average |
---|---|---|
Industrials | 19.720 | 19.728 |
Technology | 16.290 | 14.782 |
Consumer Cyclical | 13.090 | 10.796 |
Financial Services | 12.400 | 20.046 |
Healthcare | 11.480 | 7.738 |
Consumer Defensive | 8.430 | 7.356 |
Basic Materials | 7.700 | 5.762 |
Utilities | 5.220 | 5.860 |
Energy | 5.020 | 4.212 |
Communication Services | 0.530 | 5.542 |
Real Estate | 0.130 | 2.180 |
Number of long holdings: 79
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CM-AM PEA Securite RC | FR0010455808 | 7.09 | 11,750.000 | +0.01% | |
Hermes International | FR0000052292 | 4.63 | 2,075.00 | +1.42% | |
TotalEnergies SE | FR0000120271 | 3.81 | 52.51 | -1.24% | |
Air Liquide | FR0000120073 | 3.57 | 175.74 | +1.19% | |
BSO Euro Santé I | FR00140089F3 | 2.68 | - | - | |
L'Oreal | FR0000120321 | 2.62 | 388.15 | +2.32% | |
Dassault Systemes | FR0014003TT8 | 2.52 | 26.77 | +0.98% | |
BSO PME | FR0011833052 | 2.45 | - | - | |
ASML Holding | NL0010273215 | 2.38 | 640.60 | +1.06% | |
Santander | ES0113900J37 | 2.00 | 8.1360 | +1.51% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reflex Opportunites | 7.95M | 2.19 | 2.31 | 1.50 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review